• Science and Research

  This Treatment Improves Lung Function in CF, Interim Data Shows

  Posted by cystic-fibrosis-news-moderator on August 7, 2019 at 7:37 pm

  

  A single dose of Translate Bio’s first-in-class mRNA therapy MRT5005 may improve lung function in cystic fibrosis, interim Phase 1/2 trial data shows. Click here to read more about it.

  What are your thoughts about this study and its findings?

  cystic-fibrosis-news-moderator replied 4 years, 8 months ago 1 Member · 0 Replies
• 0 Replies

Log In to Reply